Where does Steve Tregay work?

Steve Tregay is Managing Partner at Mission Biocapital and Board director at Alessa Therapeutics.

What check size does Steve Tregay write?

Steve Tregay typically writes checks of $500K.

What boards does Steve Tregay sit on?

Steve Tregay holds tracked board seats at Alessa Therapeutics, Compass Therapeutics LLC.

Where did Steve Tregay go to school?

Steve Tregay studied at Harvard University (Ph.D., MS); Davidson College (BS, Chemistry).

Steve Tregay

Investor

Managing Partner at Mission Biocapital · Board director at Alessa Therapeutics

Cambridge, Massachusetts

Writes $500K checks · typically $1.5M

About

Steve Tregay, a big‑pharma executive, venture capitalist and biotech founder‑CEO, serves as founding CEO and guides companies from research to clinical development while chairing LabCentral, building shared labs in Cambridge.

Contact· self-published, not guessed

s•••@missionbiocapital.comreveal

Invests in

AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials

Board director at Alessa Therapeutics

Intro paths

→

In turn, Steve can intro founders to Alessa Therapeutics's investors below.

Alessa Therapeutics's investors · 4

Cure VenturesBoston · since 2025 Mission Bay CapitalSan Francisco Mission BiocapitalSan Francisco · $500K checks · since 2025 National Institutes of Health (NIH)since 2021

Co-founders at Alessa Therapeutics

Pamela MunsterFounder, Chief Scientific Advisor and Director

Experience

Mission BioCapitalManaging General Partnercurrent2019 — presentCambridge, MA
FORMA TherapeuticsFounder, President and CEO2008 — 2019
Compass Therapeutics LLCFounder and Chairman of the Board of Directors2015 — 2019Cambridge MA
Novartis Venture FundManaging Director2006 — 2009
Novartis Institutes for BioMedical Research (NIBR)Executive Director2004 — 2006
Array BioPharmaBusiness Development2001 — 2004

Skills & more

Drug Discovery99Biotechnology99Pharmaceutical Industry99Drug Design21Drug Development94Medicinal Chemistry23Oncology99Lifesciences37Technology Transfer47Clinical Development41CRO14Cancer9

+12 more

ChemistryOrganic ChemistryBiopharmaceuticalsCommercializationNeuroscienceGLPBiomarkersVenture CapitalClinical TrialsBiochemistryPharmacologyGMP

From Steve's professional profile.

Deals · 1

Compass Therapeutics LLCBoard seat

via Mission Biocapital · filed Jul 2018 · $170.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Alessa Therapeutics

Per SEC Form D filings.

Colleagues at Mission Biocapital

Cassidy Blundell

Partner at Mission Biocapital

Chaya Patel

Principal at Mission Biocapital

Chris Carlin

Chief Operations Officer and Chief Compliance Officer at Mission Biocapital

Clay Rowland

Investment Associate at Mission Biocapital

Douglas Crawford

Managing General Partner at Mission Biocapital

Jennifer Griffin

Partner at Mission Biocapital

Johannes Fruehauf

General Partner at Mission Biocapital

Josephine Brysting

Investment Analyst at Mission Biocapital

Frequently asked questions

Who is Steve Tregay?: Steve Tregay, a big‑pharma executive, venture capitalist and biotech founder‑CEO, serves as founding CEO and guides companies from research to clinical development while chairing LabCentral, building shared labs in Cambridge.
Where does Steve Tregay work?: Steve Tregay is Managing Partner at Mission Biocapital and Board director at Alessa Therapeutics.
What does Steve Tregay invest in?: Steve Tregay invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
What check size does Steve Tregay write?: Steve Tregay typically writes checks of $500K.
What boards does Steve Tregay sit on?: Steve Tregay holds tracked board seats at Alessa Therapeutics, Compass Therapeutics LLC.
Where did Steve Tregay go to school?: Steve Tregay studied at Harvard University (Ph.D., MS); Davidson College (BS, Chemistry).